Novartis AG (TSX:NVS)

Market Cap	354.13B
Revenue (ttm)	78.52B
Net Income (ttm)	20.05B
Shares Out	n/a
EPS (ttm)	10.17
PE Ratio	17.66
Forward PE	15.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,248
Open	25.03
Previous Close	25.03
Day's Range	25.03 - 25.03
52-Week Range	20.11 - 25.15
Beta	n/a
RSI	63.49
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: NVS

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD